Thiamine dose in alcohol withdrawal and dependency
Reading File
Finding Sources
Searching PubMed
thiamine supplementation alcohol withdrawal Wernicke encephalopathy dose
Searching the Web
thiamine dose alcohol withdrawal dependency guidelines 2024 2025
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive data from authoritative sources. Here is the full answer:
Thiamine (Vitamin B1) Dosing in Alcohol Withdrawal and Dependency
Thiamine deficiency is universal in alcohol-dependent patients due to poor dietary intake, impaired intestinal absorption, and abnormal metabolism. The primary risk is Wernicke's encephalopathy (WE), which can progress irreversibly to Korsakoff syndrome if untreated. Thiamine must always be given before any glucose/carbohydrate load, as glucose metabolism rapidly depletes thiamine and can precipitate WE.
1. Prophylactic Oral Thiamine - Low-Risk Patients
For patients without neuropsychiatric complications and with an adequate diet:
| Setting | Dose | Duration |
|---|---|---|
| Outpatient / community | 100-300 mg orally, daily | During withdrawal; continue 100 mg/day for 4-9 days after (1-2 weeks total) |
| Ongoing alcohol dependence (continued drinking) | 100-300 mg orally, daily | Indefinitely while drinking continues |
| After successful withdrawal | 100 mg orally, daily | Continue for 6 weeks post-withdrawal; stop if abstinent and nutritional status restored |
- The Maudsley Prescribing Guidelines (15th ed.) recommend 300 mg/day orally for low-risk drinkers during assisted alcohol withdrawal.
- NICE and Australian alcohol treatment guidelines recommend 100 mg BD or TDS (200-300 mg/day total) orally for prophylaxis in the community.
2. Prophylactic Parenteral Thiamine - High-Risk Patients
Oral absorption is unreliable in alcoholic/malnourished patients - parenteral is preferred for anyone with:
- Malnourishment or risk of malnutrition (low BMI <18, significant weight loss, poor diet)
- Decompensated liver disease
- Memory disturbance or peripheral neuropathy
- Previous history of WE
- Attending ED or admitted to hospital with acute illness/injury
| Setting | Dose | Duration |
|---|---|---|
| Community | IM thiamine 200-300 mg once daily | At least 3 days |
| Hospital (prophylaxis) | IM or IV thiamine 200-300 mg once daily | 3-5 days with daily clinical review |
- Maudsley Guidelines, p. 512; NHS SPS guidance
3. Treatment of Suspected or Confirmed Wernicke's Encephalopathy
WE is underdiagnosed - the classic triad (ophthalmoplegia, ataxia, confusion) is rarely complete. A presumptive diagnosis should be made and treatment started immediately if any single feature is present (ataxia, hypothermia, hypotension, confusion, ophthalmoplegia/nystagmus, memory disturbance, unconsciousness).
Do not wait for lab confirmation.
| Stage | Dose | Route | Duration |
|---|---|---|---|
| Acute WE / high suspicion | 500 mg IV immediately | IV (infuse over 30-60 min in 100 mL 0.9% saline) | Then continue |
| Ongoing treatment | 300-500 mg IV TDS (three times daily) | IV | 3-5 days minimum |
| If still symptomatic after 5 days | 300-500 mg IV once daily | IV | Continue until no further improvement |
| Step-down after acute phase | 100 mg TDS IV/IM for first week | Parenteral | ~7 days |
| Maintenance once improving | 100-300 mg orally daily | Oral | Weeks |
- Bradley and Daroff's Neurology in Clinical Practice, p. 1803; WACHS Guideline; NHS SPS
Note: 500 mg IV TDS is preferred over 200 mg TDS when WE is clinically suspected, as case reports suggest 200 mg may be inadequate in some patients with chronic alcohol use.
4. Key Practical Points
- IV > IM > oral in the acute setting - intestinal absorption is unreliable in alcoholic patients.
- Always give thiamine before glucose (including IV dextrose/saline, TPN). A glucose load in a thiamine-deficient patient can precipitate acute WE.
- Magnesium is a cofactor for thiamine-dependent enzymes - check and replete serum magnesium alongside thiamine.
- Thiamine is considered very safe. IV doses should be infused over 30 minutes (up to 60 minutes) to reduce rare risk of hypersensitivity.
- IM injections are limited to 100 mg per dose due to volume constraints - if higher doses are required, IV access is needed.
- If the patient remains alcohol-dependent and is not abstinent, thiamine should be continued indefinitely.
Summary Table
| Clinical Scenario | Route | Dose | Frequency | Duration |
|---|---|---|---|---|
| Low-risk, adequate diet, community detox | Oral | 100-300 mg | Once daily | 1-2 weeks |
| Ongoing alcohol dependency (no WE risk) | Oral | 100 mg | Once daily | Indefinitely |
| High-risk (malnourished), community | IM | 200-300 mg | Once daily | ≥3 days |
| High-risk, hospital admission | IV/IM | 200-300 mg | Once daily | 3-5 days |
| Suspected/confirmed WE | IV | 500 mg | TDS | ≥3-5 days, until improved |
| Post-WE maintenance | Oral | 100-300 mg | Daily | Weeks |
Sources: Maudsley Prescribing Guidelines (15th ed.), p. 511-512; Bradley and Daroff's Neurology in Clinical Practice, p. 1803; The Washington Manual of Medical Therapeutics; NHS SPS Thiamine Guidance; Australian Alcohol Treatment Guidelines (alcoholtreatmentguidelines.com.au)
This is a shared conversation. Sign in to Orris to start your own chat.